Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier

A Salmonella typhimurium aroA mutant has been used as a live carrier to immunize mice against tetanus. Plasmid pTETtac4, which expresses a 50-kilodalton fragment of tetanus toxin (fragment C) under the control of the tac promoter, was introduced into SL3261 aroA. When used as a live vaccine and administered orally or intravenously, this strain was able to induce protective immunity in mice against a lethal tetanus toxin challenge. When plasmid pTETtac2, which contains the lacI gene, was used, no immunity was obtained, indicating that the expression of fragment C was repressed in vivo. We believe that this is the first example of a successful oral vaccination that uses an attenuated bacterial carrier to deliver a protective antigen derived from tetanus toxin.

[1]  N. Fairweather,et al.  Expression of Tetanus Toxin Fragment C in E. coli: Its Purification and Potential Use as a Vaccine , 1989, Nature Biotechnology.

[2]  G. Dougan,et al.  Isolation of orally attenuated Salmonella typhimurium following TnphoA mutagenesis , 1989, Infection and immunity.

[3]  G. Dougan,et al.  Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo , 1989, Infection and immunity.

[4]  G. Dougan,et al.  Construction and characterization of vaccine strains of Salmonella harboring mutations in two different aro genes. , 1988, The Journal of infectious diseases.

[5]  J. Ou,et al.  Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. , 1988, Science.

[6]  G. Dougan,et al.  Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice , 1988, Infection and immunity.

[7]  N. Fairweather,et al.  Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli , 1987, Infection and immunity.

[8]  G. Dougan,et al.  Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. , 1987, Microbial pathogenesis.

[9]  K. James,et al.  Isotype responses of mice to tetanus-toxoid preparations. , 1986, Journal of medical microbiology.

[10]  A. Henschen,et al.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. , 1986, The EMBO journal.

[11]  N. Fairweather,et al.  The complete nucleotide sequence of tetanus toxin. , 1986, Nucleic acids research.

[12]  N. Fairweather,et al.  Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli , 1986, Journal of bacteriology.

[13]  T. Helting,et al.  Analysis of the immune response to papain digestion products of tetanus toxin. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

[14]  A. J. Sheppard,et al.  Production and characterization of monoclonal antibodies to tetanus toxin , 1984, Infection and immunity.

[15]  J. Brosius,et al.  Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. , 1983, Gene.

[16]  J. Ryu,et al.  Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification , 1983, Journal of bacteriology.

[17]  F. Carraro,et al.  Naturally acquired antibodies to tetanus toxin in humans and animals from the galápagos islands. , 1983, The Journal of infectious diseases.

[18]  B. Stocker,et al.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines , 1981, Nature.

[19]  T. Helting,et al.  Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. , 1977, The Journal of biological chemistry.

[20]  S. van Heyningen.  Binding of ganglioside by the chains of tetanus toxin , 1976, FEBS letters.

[21]  R. Germanier,et al.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. , 1975, The Journal of infectious diseases.

[22]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.